Satsuma Pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers. STS101 is Satsuma's lead product candidate. STS101 is a potential best-in-class therapy for migraine that combines the gold-standard anti-migraine drug, dihydroergotamine (DHE), with unique and proprietary dry-powder nasal formulation and drug delivery device technologies created and developed over the pas...
Satsuma Pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers. STS101 is Satsuma's lead product candidate. STS101 is a potential best-in-class therapy for migraine that combines the gold-standard anti-migraine drug, dihydroergotamine (DHE), with unique and proprietary dry-powder nasal formulation and drug delivery device technologies created and developed over the past 15 years by SNBL that enable rapid absorption with high bioavailability of drugs delivered via the nose.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.